Bioorganic & Medicinal Chemistry Letters · 2018 · 17 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologySynthetic Medicinal ChemistryEnzyme InhibitionHit-to-lead OptimizationPotency OptimizationReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsBiological Evaluation ReportBruton Tyrosine KinaseBruton's Tyrosine Kinase InhibitorsBtk InhibitorsKinase Inhibitor Library DesignSmall Molecule Tyrosine Kinase InhibitorsTyrosine Kinase Inhibition
14
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · New England Journal of Medicine · 2015 · 931 citations · Full text
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 891 citations · Full text
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 675 citations